000813 德展健康
收盘竞价 10-13 14:58:21
资讯
新帖
简况
股市必读：德展健康新发布《关于全资子公司创新药WYY获得美国FDA新药临床试验批准通知的公告》
证券之星 · 09-29
股市必读：德展健康新发布《关于全资子公司创新药WYY获得美国FDA新药临床试验批准通知的公告》
德展健康(000813.SZ)子公司创新药WYY026B注射液获得美国FDA新药临床试验批准
智通财经 · 09-28
德展健康(000813.SZ)子公司创新药WYY026B注射液获得美国FDA新药临床试验批准
股市必读：德展健康（000813）9月17日披露最新机构调研信息
证券之星 · 09-18
股市必读：德展健康（000813）9月17日披露最新机构调研信息
德展健康：9月17日接受机构调研，申万宏源参与
证券之星 · 09-17
德展健康：9月17日接受机构调研，申万宏源参与
德展健康：公司将根据公司发展战略，聚焦主业
证券之星 · 09-08
德展健康：公司将根据公司发展战略，聚焦主业
德展健康：VGX-3100Ⅲ期临床试验揭盲并取得积极顶线结果
证券之星 · 09-08
德展健康：VGX-3100Ⅲ期临床试验揭盲并取得积极顶线结果
异动快报：德展健康（000813）9月7日14点42分触及涨停板
证券之星 · 09-07
异动快报：德展健康（000813）9月7日14点42分触及涨停板
德展健康（000813）披露控股股东解除融资融券业务公告，9月3日股价上涨10.06%
证券之星 · 09-03
德展健康（000813）披露控股股东解除融资融券业务公告，9月3日股价上涨10.06%
德展健康（000813）披露2026年半年度报告，8月31日股价下跌4.9%
证券之星 · 08-31
德展健康（000813）披露2026年半年度报告，8月31日股价下跌4.9%
股市必读：德展健康中报 - 第二季度单季净利润同比下降14.24%
证券之星 · 08-31
股市必读：德展健康中报 - 第二季度单季净利润同比下降14.24%
德展健康（000813）2026年中报简析：净利润同比下降35.58%
证券之星 · 08-30
德展健康（000813）2026年中报简析：净利润同比下降35.58%
德展健康(000813)6月30日股东户数5.09万户，较上期减少10.6%
证券之星 · 08-29
德展健康(000813)6月30日股东户数5.09万户，较上期减少10.6%
图解德展健康中报：第二季度单季净利润同比下降14.24%
证券之星 · 08-29
图解德展健康中报：第二季度单季净利润同比下降14.24%
股市必读：德展健康新发布《关于持股5%以上股东股份被冻结的公告》
证券之星 · 08-10
股市必读：德展健康新发布《关于持股5%以上股东股份被冻结的公告》
德展健康（000813）披露持股5%以上股东股份被冻结公告，8月7日股价上涨4.26%
证券之星 · 08-07
德展健康（000813）披露持股5%以上股东股份被冻结公告，8月7日股价上涨4.26%
德展健康：持股5%以上股东1.30亿股股份被司法冻结
格隆汇 · 08-07
德展健康：持股5%以上股东1.30亿股股份被司法冻结
德展健康（000813）披露2026年半年度业绩预告，7月15日股价上涨2.37%
证券之星 · 07-15
德展健康（000813）披露2026年半年度业绩预告，7月15日股价上涨2.37%
股市必读：德展健康（000813）预计2026年1-6月扣非后净利润亏损3900万元至7600万元
证券之星 · 07-15
股市必读：德展健康（000813）预计2026年1-6月扣非后净利润亏损3900万元至7600万元
德展健康（000813）披露简式权益变动报告书，7月1日股价上涨2.97%
证券之星 · 07-01
德展健康（000813）披露简式权益变动报告书，7月1日股价上涨2.97%
6月30日德展健康发布公告，股东减持36.65万股
证券之星 · 06-30
6月30日德展健康发布公告，股东减持36.65万股
加载更多
公司概况
公司名称：
德展大健康股份有限公司
所属行业：
医药制造业
上市日期：
1998-05-19
主营业务：
德展大健康股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是阿托伐他汀钙片（阿乐）、氨氯地平阿托伐他汀钙片（尼乐）、华法林钠片、盐酸曲美他嗪片（奉乐）、盐酸胺碘酮片、泛昔洛韦片（凡乐）、硫唑嘌呤片、羟基脲片、秋水仙碱片、磷酸奥司他韦胶囊。
发行价格：
4.57
{"stockData":{"symbol":"000813","market":"SZ","secType":"STK","nameCN":"德展健康","latestPrice":3.22,"timestamp":1791874701000,"preClose":3.21,"halted":0,"volume":20823063,"delay":0,"changeRate":0.0031,"floatShares":2097000000,"shares":2097000000,"eps":-0.172,"marketStatus":"收盘竞价","change":0.01,"latestTime":"10-13 14:58:21","open":3.19,"high":3.25,"low":3.16,"amount":66720700,"amplitude":0.028,"askPrice":3.22,"askSize":954,"bidPrice":3.22,"bidSize":954,"shortable":0,"etf":0,"ttmEps":-0.172,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791874800000},"marketStatusCode":4,"adr":0,"adjPreClose":3.21,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":3.53,"lowLimit":2.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2097105540,"isCdr":false,"pbRate":1.47,"roa":"--","roe":"--","epsLYR":-0.1633,"committee":0.613139,"marketValue":6753000000,"turnoverRate":0.0099,"status":0,"floatMarketCap":6751000000},"requestUrl":"/m/hq/s/000813/","defaultTab":"news","newsList":[{"id":"2671254590","title":"股市必读：德展健康新发布《关于全资子公司创新药WYY获得美国FDA新药临床试验批准通知的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254590","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671254590?lang=zh_cn&edition=full","pubTime":"2026-09-29 01:30","pubTimestamp":1790616636,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，德展健康报收于3.2元，上涨0.0%，换手率0.93%，成交量19.58万手，成交额6234.7万元。公司公告汇总：全资子公司创新药WYY026B注射液获美国FDA新药临床试验批准，适应症为急性缺血性脑卒中。此次获批对公司近期业绩无重大影响，后续仍需开展临床试验并经审批方可上市，研发过程存在周期长、风险高等不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0060","BK0239","159992","BK1574","000813","BK0114","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670262238","title":"德展健康(000813.SZ)子公司创新药WYY026B注射液获得美国FDA新药临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670262238","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670262238?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:08","pubTimestamp":1790586484,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德展健康 发布公告，公司全资子公司北京红惠新医药科技有限公司于近日收到美国食品药品监督管理局通知，由红惠新申报的WYY026B注射液药品临床试验申请已获得美国FDA批准，开展相关临床研究。本次WYY026B注射液在美国的临床试验申请获批，是该款药品研发进程中的重要进展，将进一步提升公司在心脑血管药品研发领域的核心竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMED","BK0060","BK4585","BK4588","000813","MEDX","06978","IBBQ","BK1161","BK0114","BK0239","MDTX","159992","IBBJ","LABU","BK1574","LNGR","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999218","title":"股市必读：德展健康（000813）9月17日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668999218?lang=zh_cn&edition=full","pubTime":"2026-09-18 00:49","pubTimestamp":1789663750,"startTime":"0","endTime":"0","summary":"截至2026年9月17日收盘，德展健康报收于3.21元，上涨0.31%，换手率0.97%，成交量20.31万手，成交额6516.85万元。当日关注点交易信息汇总：9月17日主力资金净流出95.08万元，占总成交额1.46%。机构调研要点9月17日特定对象调研,现场交流创新药WYY注射液急性缺血性脑卒中适应症已向FD和NMP提交IND申请并完成Pre-IND，获审评意见，预计下半年完成IND申报。抗血栓创新药ZT已确定候选药物，进入临床前PCC研究阶段，开发优势为用药安全性及更低出血风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800000424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0114","BK0239","000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668913965","title":"德展健康：9月17日接受机构调研，申万宏源参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2668913965","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668913965?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:01","pubTimestamp":1789639265,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月17日德展健康发布公告称公司于2026年9月17日接受机构调研，申万宏源张静含 郭旭参与。如有后续进展，公司将按规定及时履行信息披露义务。融资融券数据显示该股近3个月融资净流出2693.94万，融资余额减少；融券净流入61.05万，融券余额增加。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700029782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","BK0012","06806","BK0183","BK0239","BK0276","BK0188","BK0114","000166","000813","BK1147","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665737361","title":"德展健康：公司将根据公司发展战略，聚焦主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2665737361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665737361?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:51","pubTimestamp":1788871909,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康(000813)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：公司业绩越来越差，向退市方的走去，公司有没有重组或大股东有没有注入优质资产的计划？德展健康回复：尊敬的投资者您好，公司将根据公司发展战略，聚焦主业，扎实稳步推动各项工作，有关公司重大事项请以公司公告为准。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800034473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813","BK0114","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665337364","title":"德展健康：VGX-3100Ⅲ期临床试验揭盲并取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2665337364","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665337364?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:51","pubTimestamp":1788871905,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康09月07日在投资者关系平台上答复投资者关心的问题。德展健康回复：尊敬的投资者您好，参股公司东方略在研重点产品VGX-3100的首个适应症Ⅲ期临床试验已经揭盲并取得积极的顶线结果，达到预设的主要疗效终点。具体请见公司2026年5月发布的《关于参股公司合作研发项目临床试验揭盲结果的公告》。如有后续进展，公司将按规定及时履行信息披露义务。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800034471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0114","000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665928813","title":"异动快报：德展健康（000813）9月7日14点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665928813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665928813?lang=zh_cn&edition=full","pubTime":"2026-09-07 14:45","pubTimestamp":1788763529,"startTime":"0","endTime":"0","summary":"证券之星9月7日盘中消息，14点42分德展健康（000813）触及涨停板。其所属行业化学制药目前上涨。领涨股为德展健康。该股为饮料，新疆国企改革，医美概念热股，当日饮料概念上涨1.84%，新疆国企改革概念上涨1.72%，医美概念上涨1.23%。9月4日的资金流向数据方面，主力资金净流出3048.28万元，占总成交额6.22%，游资资金净流入3744.57万元，占总成交额7.64%，散户资金净流出696.29万元，占总成交额1.42%。近5日资金流向一览见下表：德展健康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700013744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0060","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870585","title":"德展健康（000813）披露控股股东解除融资融券业务公告，9月3日股价上涨10.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870585","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664870585?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:02","pubTimestamp":1788444144,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，德展健康报收于3.61元，较前一交易日上涨10.06%，最新总市值为75.71亿元。该股当日开盘3.28元，最高3.61元，最低3.26元，成交额达4.03亿元，换手率为5.59%。近日，德展大健康股份有限公司发布公告称，公司控股股东新疆凯迪投资有限责任公司已于2026年9月2日将其原用于融资融券业务的196,200,000股公司股份全部从中信建投证券客户信用交易担保证券账户转回至普通证券账户，解除相关融资融券业务。上述股份所有权未发生转移。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0060","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071265","title":"德展健康（000813）披露2026年半年度报告，8月31日股价下跌4.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071265","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663071265?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:03","pubTimestamp":1788170592,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，德展健康报收于3.3元，较前一交易日下跌4.9%，最新总市值为69.2亿元。该股当日开盘3.47元，最高3.47元，最低3.29元，成交额达1.33亿元，换手率为1.91%。公司于近日披露《2026年半年度报告》。报告显示，德展健康2026年上半年实现营业收入142,633,396.76元，同比下降14.26%；归属于上市公司股东的净利润为-58,198,571.39元，同比亏损扩大35.58%；扣除非经常性损益后的净利润为-59,269,501.73元，同比减少30.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100025846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0114","000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047455","title":"股市必读：德展健康中报 - 第二季度单季净利润同比下降14.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047455","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663047455?lang=zh_cn&edition=full","pubTime":"2026-08-31 05:50","pubTimestamp":1788126622,"startTime":"0","endTime":"0","summary":"关于2026年半年度计提资产减值准备的公告截至2026年6月30日，计提资产减值准备共计1,462.87万元，其中应收账款514.26万元、其他应收款630.79万元、存货317.82万元；计入2026年1月1日至6月30日报告期间，减少当期利润总额1,462.87万元；已履行内部审批程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663253048","title":"德展健康（000813）2026年中报简析：净利润同比下降35.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663253048","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663253048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:21","pubTimestamp":1788042074,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期德展健康发布2026年中报。根据财报显示，德展健康净利润同比下降35.58%。截至本报告期末，公司营业总收入1.43亿元，同比下降14.26%，归母净利润-5819.86万元，同比下降35.58%。按单季度数据看，第二季度营业总收入5400.98万元，同比下降29.93%，第二季度归母净利润-2377.56万元，同比下降14.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2663638012","title":"德展健康(000813)6月30日股东户数5.09万户，较上期减少10.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663638012","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663638012?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:12","pubTimestamp":1787994755,"startTime":"0","endTime":"0","summary":"证券之星消息，近日德展健康披露，截至2026年6月30日公司股东户数为5.09万户，较3月31日减少6038.0户，减幅为10.6%。在化学制药行业个股中，德展健康股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，德展健康区间跌幅为13.92%，在此期间股东户数减少6038.0户，减幅为10.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0114","000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018671","title":"图解德展健康中报：第二季度单季净利润同比下降14.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018671","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663018671?lang=zh_cn&edition=full","pubTime":"2026-08-29 02:07","pubTimestamp":1787940471,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康2026年中报显示，上半年度公司主营收入1.43亿元，同比下降14.26%；归母净利润-5819.86万元，同比下降35.58%；扣非净利润-5926.95万元，同比下降30.28%；其中2026年第二季度，公司单季度主营收入5400.98万元，同比下降29.93%；单季度归母净利润-2377.56万元，同比下降14.24%；单季度扣非净利润-2387.98万元，同比下降10.6%；负债率5.7%，投资收益-142.76万元，财务费用-4720.91万元，毛利率37.11%。财报数据概要请见下图:本文数据来源于德展健康2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900005911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670487","title":"股市必读：德展健康新发布《关于持股5%以上股东股份被冻结的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670487?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:26","pubTimestamp":1786296371,"startTime":"0","endTime":"0","summary":"公司公告汇总：持股5%以上股东陈致文龙所持全部股份被上海市第二中级人民法院司法冻结，冻结期自2026年8月6日至2029年8月5日。公司公告汇总关于持股5%以上股东股份被冻结的公告德展大健康股份有限公司于2026年8月8日发布公告，持股5%以上股东陈致文龙所持有的公司全部股份被司法冻结。陈致文龙非公司控股股东或实际控制人，本次股份冻结不会对公司日常经营管理造成影响。公司已收到相关告知函及证券登记结算机构出具的文件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0114","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644318","title":"德展健康（000813）披露持股5%以上股东股份被冻结公告，8月7日股价上涨4.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644318","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644318?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:17","pubTimestamp":1786112250,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，德展健康报收于3.43元，较前一交易日上涨4.26%，最新总市值为71.93亿元。近日，德展大健康股份有限公司发布公告称，持股5%以上股东陈致文龙所持有的公司全部股份被司法冻结。本次冻结股份数量为129,500,000股，占其所持股份比例100%，占公司总股本比例6.18%。陈致文龙非公司控股股东或实际控制人，本次股份冻结不会对公司日常经营管理造成影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700040958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0060","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616609","title":"德展健康：持股5%以上股东1.30亿股股份被司法冻结","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616609","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616609?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:51","pubTimestamp":1786092704,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","000813","BK0060","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745997","title":"德展健康（000813）披露2026年半年度业绩预告，7月15日股价上涨2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745997","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651745997?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:34","pubTimestamp":1784108080,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，德展健康报收于3.45元，较前一交易日上涨2.37%，最新总市值为72.35亿元。该股当日开盘3.34元，最高3.52元，最低3.32元，成交额达1.81亿元，换手率为2.51%。德展大健康股份有限公司于2026年7月15日发布2026年半年度业绩预告，预计2026年1月1日至6月30日期间归属于上市公司股东的净利润亏损3,800万元至7,500万元，较上年同期亏损4,292.65万元，变动幅度为下降74.72%至减亏11.48%；扣除非经常性损益后的净利润亏损3,900万元至7,600万元，上年同期为亏损4,549.32万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813","BK0239","BK0114","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651488052","title":"股市必读：德展健康（000813）预计2026年1-6月扣非后净利润亏损3900万元至7600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651488052","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651488052?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:24","pubTimestamp":1784049851,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，德展健康报收于3.37元，上涨2.43%，换手率2.01%，成交量42.1万手，成交额1.4亿元。当日关注点交易信息汇总：7月14日主力资金净流入1377.03万元。业绩披露要点：德展健康预计2026年1-6月归属净利润亏损3800万元至7500万元。公司公告汇总：业绩预告显示亏损同比变动幅度为下降74.72%至减亏11.48%，主要因深化“药品+医疗+健康”业务格局、加大创新研发及集采政策影响。本次数据为公司财务部门初步测算，未经会计师事务所审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500001872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648651475","title":"德展健康（000813）披露简式权益变动报告书，7月1日股价上涨2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648651475","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648651475?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:19","pubTimestamp":1782901155,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，德展健康报收于3.12元，较前一交易日上涨2.97%，最新总市值为65.43亿元。该股当日开盘3.04元，最高3.13元，最低2.98元，成交额达1.17亿元，换手率为1.82%。公司于近日披露《简式权益变动报告书》。公告显示，美林控股集团有限公司因司法强制执行，通过集中竞价和司法拍卖方式被动减持德展大健康股份有限公司股份。本次权益变动后，美林控股持股数量由207,402,482股减少至103,801,842股，持股比例由9.58%降至4.95%，不再为公司5%以上股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100036047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0060","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647553786","title":"6月30日德展健康发布公告，股东减持36.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647553786","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647553786?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:01","pubTimestamp":1782820878,"startTime":"0","endTime":"0","summary":"证券之星消息，6月30日德展健康发布公告《德展健康:德展大健康股份有限公司简式权益变动报告书》，其股东美林控股集团有限公司于2025年7月24日合计减持36.65万股，占公司目前总股本的0.0169%，变动期间该股股价上涨4.24%，截止7月24日收盘报3.93元。股东增减持详情见下表：根据德展健康2026年一季报公布的十大股东详情如下：本文数据来源于德展健康公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000041312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0114","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791874706966,"stockEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.0503},{"period":"3month","weight":-0.0475},{"period":"6month","weight":-0.0802},{"period":"1year","weight":-0.2465},{"period":"ytd","weight":-0.1641}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"德展大健康股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"50927人(较上一季度减少10.60%)","perCapita":"41169股","listingDate":"1998-05-19","address":"新疆维吾尔自治区乌鲁木齐市天山区金银路53号金融大厦1611室","registeredCapital":"209710万元","survey":" 德展大健康股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是阿托伐他汀钙片（阿乐）、氨氯地平阿托伐他汀钙片（尼乐）、华法林钠片、盐酸曲美他嗪片（奉乐）、盐酸胺碘酮片、泛昔洛韦片（凡乐）、硫唑嘌呤片、羟基脲片、秋水仙碱片、磷酸奥司他韦胶囊。","listedPrice":4.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德展健康(000813)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德展健康(000813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德展健康,000813,德展健康股票,德展健康股票老虎,德展健康股票老虎国际,德展健康行情,德展健康股票行情,德展健康股价,德展健康股市,德展健康股票价格,德展健康股票交易,德展健康股票购买,德展健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德展健康(000813)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德展健康(000813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}